Tag: CPAP Therapy
In brief: ACCESS Model expands, Merits enters new chapter, CPAP reduces mortality
September 18, 2026HME News Staff
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) will expand an existing initiative to offer technology-support care options to Medicare beneficiaries who have chronic obstructive pulmonary disease (COPD) and heart failure.
The Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model currently offers care options for people with high blood pressure, diabetes, chronic musculoskeletal pain and depression.
“We built ACCESS because too many people with...
Accendra Health ready to put weak Q2 in rear view
August 14, 2026Theresa Flaherty
RICHMOND, Va. – Accendra Health’s second quarter results “did not meet expectations,” thanks to lower revenue growth and other challenges, but executives pointed to several growth opportunities in upcoming quarters and overall improvement in its sleep business as evidence of the company’s strength.
For the quarter, the company saw lower revenue growth, slower than-expected collection recovery and a delay in cost reduction initiatives, said Edward Pesicka, president...
In brief: Bid calculators & readiness, Tactile settlement, CPAP study
July 17, 2026HME News Staff
WASHINGTON – AAHomecare has created competitive bidding calculators designed to help HME providers better understand the financial impact of submitting bids for the next round of Medicare’s competitive bidding program.
The calculators are based on those previously released by the Centers for Medicare & Medicaid Services (CMS), with several enhancements intended to make them more practical and informative, the association says.
Key features of the calculators include:
Bid limit...
HME Medical adds respiratory, builds West Coast hub
July 2, 2026Tracy Orzel
RICHMOND, British Columbia – HME Medical Distribution’s new partnership with Yuwell marks more than an expansion into CPAP and respiratory products—it’s part of a broader strategy to evolve from a regional DME provider into a national medical equipment distributor.
“It’s a process that takes years and years, as we continue that transformation – whether that’s adding new products and new services, expanding our physical warehouse locations,”...
New therapies challenge CPAP, but providers aren’t shifting yet
June 19, 2026Liz Beaulieu, Editor
YARMOUTH, Maine – There may be an increasing number of options to treat obstructive sleep apnea (OSA), but CPAP remains the top choice, say 68% of respondents to a recent HME Newspoll.
“The sleep apnea treatment landscape is becoming increasingly diverse, which is good news for patients,” wrote one respondent. “New options, such as oral appliances, implantable devices and emerging medications may help people who struggle with CPAP therapy. That said, CPAP remains the gold...
BleepSleep launches new Shopify-powered storefront
June 2, 2026HME News Staff
CHAPEL HILL, N.C. – BleepSleep has launched a redesigned, direct-to-consumer Shopify store at bleepsleep.com for its mask-less, strap-free CPAP solutions, the DreamPort and Eclipse. "Too many CPAP users abandon therapy not because therapy doesn't work - but because the mask makes it unbearable,” said Stuart Heatherington, founder and CEO. “DreamPort and Eclipse were designed from the ground up to solve that. No headgear. No straps. No leaks. Just therapy that patients can...
LiViliti Health Products receives FDA clearance for CPAP sanitizer
May 4, 2026HME News Staff
SARASOTA, Fla. – LiViliti Health Products has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Paptizer 360. Classified as a Class II Respiratory Accessory Microbial Reduction Device, the Paptizer 360 provides a supplemental, at-home bacterial reduction process on compatible CPAP equipment. "This clearance marks a significant milestone for LiViliti as we continue to provide users with scientifically validated tools for their respiratory health," said...
Providers expect pick up in sleep patient volume
April 29, 2026HME News Staff
NEW YORK – Providers saw slower sleep patient volume in the last 12 months but expect improved growth in the next 12 months, according to the 1Q26 HME Sleep and Oxygen Survey from Needham.
Other sleep-related findings from the survey:
Resmed looks likely to lose flow generator market share to React Health and modest mask market share to React Health and Fisher & Paykel Healthcare in the next 12 months.
Respondents expect to shift a moderate portion of their flow generator purchases...
In brief: OIG’s PAP investigation, Oz’s Medicaid revalidation initiative, CCS’s agentic AI platform
April 27, 2026HME News Staff
WASHINGTON - Medicare payments made to suppliers for PAP devices generally complied with Medicare billing requirements, according to a new report from the Office of Inspector General (OIG).
For fiscal year 2017, the Comprehensive Error Rate Testing (CERT) Program determined continuous PAP (CPAP) devices had the second highest improper payment amount in the DMEPOS category, with estimated improper payments totaling $495 million for CPAP devices used for the treatment of obstructive sleep apnea...
AASM asks UnitedHealthcare to address delays in PAP and respiratory fulfillment
April 13, 2026HME News Staff
DARIEN, Ill. – The American Academy of Sleep Medicine (AASM) recently sent a letter to UnitedHealthcare, raising concerns about the payer’s use of Synapse Health for durable medical equipment (DME) fulfillment for CPAP therapy.
“AASM members report that operational barriers associated with Synapse Health have delayed initiation of medically necessary therapy and created avoidable administrative burden for patients, clinicians, and DME suppliers, particularly related to treatment...